Table 1.
Summarized paclitaxel- and/or cisplatin-induced ocular toxicity reported in prior and present studies
| Author(s) | Case number | Toxicity | Drug | Diagnosis |
|---|---|---|---|---|
| Kwan et al4 | 1 | Hemianopia | CDDP | Nonseminomatous germ cell testicular tumor |
| Berman and Mann8 | 1 | Cortical blindness | CDDP | Embryonic cell carcinoma of the testicle |
| Wilding et al9 | 13 | Blurred vision | CDDP | Ovarian carcinoma |
| Tan and Walsh10 | 2 | Photopsia | CDDP, PTX | Lung cancer |
| Wang et al11 | 1 | Bilateral blindness | Carmustine, CDDP | Breast carcinoma |
| Watanabe et al12 | 1 | Visual disturbance | Carboplatin | Glioblastoma |
| Wu et al13 | 1 | Intraorbital and intraocular pain | CDDP | Glioblastoma multiforme |
| Scaioli et al14 | 1 | Optic neuropathy | PTX, doxorubicin | Breast cancer |
| Modi and Dubovy15 | 1 | Maculopathy | PTX | Breast cancer |
| Joshi and Garretson16 | 1 | Cystoid macular edema | PTX | Breast cancer |
| Li et al (present study) | 1 | Bilateral blindness | CDDP, PTX | Nasopharyngeal cancer |
Abbreviations: PTX, paclitaxel; CDDP, cisplatin.